BetterLife Pharma Files April 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Jun 28, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Jun 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, pharmaceuticals
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its April 2024 6-K, standard foreign issuer update.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K for the month of April 2024, reporting on its activities as a foreign private issuer. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in Canada and operates in the pharmaceutical preparations sector. The filing was made on June 28, 2024.
Why It Matters
This filing provides an update on BetterLife Pharma's regulatory disclosures for April 2024, which is crucial for investors tracking the company's compliance and operational status.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer of the report
- Pivot Pharmaceuticals Inc. (company) — Former company name
- Neurokine Pharmaceuticals Inc. (company) — Former company name
- 20240430 (date) — Conformed period of report
- 20240628 (date) — Filed as of date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K filing is used by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.
What is BetterLife Pharma Inc.'s Standard Industrial Classification (SIC) code?
BetterLife Pharma Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What were BetterLife Pharma Inc.'s former company names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc.
On what date was this Form 6-K filed?
This Form 6-K was filed on June 28, 2024.
For which reporting period is this Form 6-K intended?
This Form 6-K is for the month of April 2024, with a conformed period of report of 20240430.
Filing Stats: 350 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-06-27 17:46:17
Filing Documents
- betrf_6k.htm (6-K) — 11KB
- betrf_ex991.htm (EX-99.1) — 178KB
- betrf_ex992.htm (EX-99.2) — 588KB
- betrf_ex993.htm (EX-99.3) — 9KB
- betrf_ex994.htm (EX-99.4) — 8KB
- betrf_ex991img1.jpg (GRAPHIC) — 4KB
- 0001477932-24-003927.txt ( ) — 801KB
Management's discussion and analysis
Management's discussion and analysis 99.2
Financial statements
Financial statements 99.3 CEO certification 99.4 CFO certification 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: June 27, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3